175 related articles for article (PubMed ID: 8878019)
1. Hyperplastic mesothelial cells within abdominal lymph nodes: mimic of metastatic ovarian carcinoma and serous borderline tumor--a report of two cases associated with ovarian neoplasms.
Clement PB; Young RH; Oliva E; Sumner HW; Scully RE
Mod Pathol; 1996 Sep; 9(9):879-86. PubMed ID: 8878019
[TBL] [Abstract][Full Text] [Related]
2. Hyperplastic mesothelial cells in pelvic and abdominal lymph node sinuses mimicking metastatic ovarian microinvasive serous borderline tumor.
Kir G; Eren S; Kir M
Eur J Gynaecol Oncol; 2004; 25(2):236-8. PubMed ID: 15032291
[TBL] [Abstract][Full Text] [Related]
3. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
4. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
[TBL] [Abstract][Full Text] [Related]
5. Ovarian sertoli-leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid sertoli-leydig cell tumors).
McCluggage WG; Young RH
Am J Surg Pathol; 2007 Apr; 31(4):592-7. PubMed ID: 17414107
[TBL] [Abstract][Full Text] [Related]
6. Mesothelial pelvic lymph node inclusions mimicking metastatic thyroid carcinoma.
Cohn DE; Folpe AL; Gown AM; Goff BA
Gynecol Oncol; 1998 Feb; 68(2):210-3. PubMed ID: 9514806
[TBL] [Abstract][Full Text] [Related]
7. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
[TBL] [Abstract][Full Text] [Related]
8. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis.
Kim HS; Yoon G; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS; Song SY
Int J Clin Exp Pathol; 2015; 8(5):5318-26. PubMed ID: 26191233
[TBL] [Abstract][Full Text] [Related]
9. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
Kadar N; Krumerman M
Gynecol Oncol; 1995 Dec; 59(3):394-7. PubMed ID: 8522262
[TBL] [Abstract][Full Text] [Related]
10. Ovarian involvement by desmoplastic small round cell tumor with leydig cell hyperplasia showing an unusual immunophenotype (cytokeratin negative, calretinin and inhibin positive) mimicking poorly differentiated sertoli leydig cell tumor.
Engohan-Aloghe C; Aubain Sommerhausen Nde S; Noël JC
Int J Gynecol Pathol; 2009 Nov; 28(6):579-83. PubMed ID: 19851210
[TBL] [Abstract][Full Text] [Related]
11. [Benign epithelial inclusions in pelvic lymph nodes. 2 case reports].
Alvarado Cabrero I; Sosa Romero A
Ginecol Obstet Mex; 2000 Feb; 68():77-81. PubMed ID: 10774109
[TBL] [Abstract][Full Text] [Related]
12. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
14. Müllerian and mesothelial lymph node involvement in patients with borderline ovarian tumors.
Eltabbakh GH; Mount SL
J Reprod Med; 2011; 56(5-6):211-8. PubMed ID: 21682116
[TBL] [Abstract][Full Text] [Related]
15. Ectopic mesothelial cell proliferation in cervical lymph nodes after severe ovarian hyperstimulation syndrome.
van der Weiden RM; Meijers CJ; Hegt VN
Fertil Steril; 2005 Mar; 83(3):739-41. PubMed ID: 15749507
[TBL] [Abstract][Full Text] [Related]
16. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
17. Fine-needle aspiration biopsy and intraoperative cytologic smear findings in a case of benign mesothelial-cell inclusions involving a lymph node: case report and review of the literature.
Paull G; Mosunjac M
Diagn Cytopathol; 2003 Sep; 29(3):163-6. PubMed ID: 12951686
[TBL] [Abstract][Full Text] [Related]
18. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
20. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
Ordi J; Schammel DP; Rasekh L; Tavassoli FA
Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
